Tag Archives: RIGL

Top 10 Heal Care Stocks To Buy For 2019

Shares of ArQule (ARQL) have risen by over 550% since I published my initial article advising readers that there were ¨several ways to win here¨. Shares have increased by around 290% since my latest update piece was published in which I stated that the stock was presenting investors with an enticing risk/reward setup into AACR.

Chart

Figure 1: ARQL daily advanced chart (Source: Finviz)

Figure 2: ARQL 15-minute chart (Source: Finviz)

Top 10 Heal Care Stocks To Buy For 2019: Honeywell International Inc.(HON)

Advisors’ Opinion:

  • [By Paul Ausick]

    Honeywell International Inc. (NYSE: HON) reported fourth-quarter and full-year 2017 results before markets opened Friday. For the quarter, the conglomerate posted adjusted diluted earnings per share (EPS) of $1.85 on revenues of $10.84 billion. In the same period a year ago, the company reported EPS of $1.74 on revenues of $9.99 billion. Fourth-quarter results also compare to consensus estimates for EPS of $1.84 and $10.75 billion in revenues.

  • [By Garrett Baldwin]

    Well, Money Morning Special Situation Strategist Tim Melvin has broken these secrets out of the vault of the Smart Money managers. And he’s sharing the Max Wealth secrets for free right here.

    Two Stocks to Watch Today: XOM, DB
    Shares of Exxon Mobil Corp. (NYSE: XOM) jumped more than 2.6% in pre-market hours after the energy giant reported earnings before the bell. The oil major reported earnings per share of $1.41, easily topping Wall Street forecasts of $1.08. Its $7.2 billion in quarterly profits were a 72% jump from the same period last year. However, the firm did fall a bit short on the revenue front. Investors liked the news that Exxon plans to restructure its upstream business to reduce costs and bolster operating cash flow by 2025. On the European front, shares of Deutsche Bank (NYSE: DB) were off another 3.72% after the German banking giant reported earnings. The embattled financial institution reported its first annual profit since 2014. However, broader uncertainty remains from investors. On Friday, look for earnings reports from Chevron Corp. (NYSE: CVX), Cigna Holding Co. (NYSE: CI), Weatherford International Plc. (NYSE: WFT), Roper Technologies Inc. (NYSE: ROP), Merck & Co. Inc. (NYSE: MRK), Honeywell International Inc. (NYSE: HON), and Johnson Controls International Plc. (NYSE: JCI).
    These 3 Stocks Are the Key to 2019’s Greatest Profits

    The 2018 midterm election was a turning point for the cannabis industry.

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s rankings:

    Can Aerospace Strength Drive Honeywell (HON) in Q1 Earnings? (finance.yahoo.com) Could Honeywell Beat Analysts’ Earnings Estimates Again? (marketrealist.com) OJets selects Honeywell for in-flight connectivity (ainonline.com) Analysts’ Views on Honeywell, Pre-1Q18 Earnings Release (marketrealist.com) Honeywell (HON) Stock Rating Reaffirmed by Cowen (americanbankingnews.com)

    A number of equities research analysts have weighed in on the company. Zacks Investment Research raised Honeywell from a “hold” rating to a “buy” rating and set a $160.00 target price for the company in a research report on Tuesday, April 3rd. Stifel Nicolaus reaffirmed a “buy” rating and set a $165.00 target price on shares of Honeywell in a research report on Friday, February 16th. Cowen reaffirmed a “buy” rating and set a $168.00 target price on shares of Honeywell in a research report on Monday, January 22nd. Robert W. Baird reaffirmed a “buy” rating and set a $187.00 target price on shares of Honeywell in a research report on Friday, January 26th. Finally, Bank of America lifted their target price on Honeywell from $117.12 to $168.00 and gave the company a “buy” rating in a research report on Friday, January 26th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $166.07.

  • [By Ethan Ryder]

    CIBC World Markets Inc. lessened its position in Honeywell International Inc. (NYSE:HON) by 5.7% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 106,160 shares of the conglomerate’s stock after selling 6,435 shares during the period. CIBC World Markets Inc.’s holdings in Honeywell International were worth $15,292,000 at the end of the most recent reporting period.

  • [By Chris Lange]

    And Honeywell International PLC (NYSE: HON) will report its fourth-quarter results on Friday. The analysts’ consensus estimates are EPS of $1.84 and $10.75 billion in revenue. The stock was last seen at $158.69 a share. The consensus price target is $166.81, and the 52-week range is $116.98 to $159.85.

Top 10 Heal Care Stocks To Buy For 2019: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Pacira Pharmaceuticals Inc (NASDAQ:PCRX) was the target of unusually large options trading activity on Wednesday. Stock investors acquired 9,610 call options on the company. This represents an increase of 5,123% compared to the typical daily volume of 184 call options.

  • [By Jon C. Ogg]

    Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) has found itself in the middle of a great opportunity but not being able to make the last mile of the race. Unfortunately, pain management in a non-opioid treatment has become an elusive target. And it’s too bad when you consider how many people have become addicted to opioids in America.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Pacira Pharmaceuticals (PCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Pacira Pharmaceuticals Inc (NASDAQ:PCRX) has been given an average rating of “Hold” by the twenty-four ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and ten have given a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $46.65.

Top 10 Heal Care Stocks To Buy For 2019: Tata Motors Ltd(TTM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News headlines about Tata Motors (NYSE:TTM) have trended somewhat positive on Monday, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Tata Motors earned a news impact score of 0.23 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.2298115164749 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Shares of Tata Motors Limited (NYSE:TTM) have been assigned an average rating of “Hold” from the eight brokerages that are currently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $30.00.

  • [By John Rosevear]

    First up is the I-Pace, the crossover SUV from Tata Motors’ (NYSE:TTM) Jaguar luxury brand. The I-Pace has already begun shipping in Europe, but it won’t arrive in the United States until the second half of 2018.

  • [By John Rosevear]

    Shares of Indian automaker Tata Motors (NYSE:TTM) fell sharply on Tuesday morning, after the company announced that its important Jaguar Land Rover subsidiary will cut production after a sharp drop in sales in China. 

  • [By Paul Ausick]

    Tata Motors Ltd. (NYSE: TTM) fell by about 2% Monday to post a new 52-week low of $23.82 after closing at $24.30 on Friday. The 52-week high is $37.62. Volume of about 3.6 million was more more than double the daily average of about 1.5 million. The company had no specific news.

  • [By Dan Caplinger]

    U.S. stocks have enjoyed years of strong gains, but the situation hasn’t been as rosy for many companies that do business across the globe. India’s Tata Motors (NYSE:TTM), which owns key car brands such as Jaguar and Land Rover, gave investors an extremely tough financial report that led to two days’ worth of severe share-price declines. Yet closer to home, Motorola Solutions (NYSE:MSI) has made a name for itself with its services to enterprise and government customers.

Top 10 Heal Care Stocks To Buy For 2019: First Trust Water ETF (FIW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Wells Fargo & Company MN decreased its stake in shares of First Trust Water ETF (NYSEARCA:FIW) by 11.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 275,540 shares of the company’s stock after selling 36,231 shares during the quarter. Wells Fargo & Company MN’s holdings in First Trust Water ETF were worth $13,256,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    First Trust ISE Water Index Fund (NYSEARCA:FIW) declared a quarterly dividend on Thursday, June 21st, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be paid a dividend of 0.0861 per share on Friday, June 29th. This represents a $0.34 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date of this dividend is Thursday, June 21st. This is a positive change from First Trust ISE Water Index Fund’s previous quarterly dividend of $0.06.

  • [By Logan Wallace]

    Raymond James & Associates increased its position in First Trust Water ETF (NYSEARCA:FIW) by 45.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 61,717 shares of the company’s stock after buying an additional 19,152 shares during the period. Raymond James & Associates’ holdings in First Trust Water ETF were worth $2,969,000 at the end of the most recent quarter.

Top 10 Heal Care Stocks To Buy For 2019: FRP Holdings, Inc.(FRPH)

Advisors’ Opinion:

  • [By Max Byerly]

    FRP Holdings Inc (NASDAQ:FRPH) VP John D. Milton, Jr. sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 14th. The stock was sold at an average price of $59.07, for a total value of $177,210.00. Following the transaction, the vice president now owns 632 shares in the company, valued at approximately $37,332.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

  • [By Joseph Griffin]

    FRP (NASDAQ:FRPH) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Saturday.

  • [By Motley Fool Transcribers]

    FRP Holdings Inc  (NASDAQ:FRPH)Q4 2018 Earnings Conference CallMarch 07, 2019, 1:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    FRP (NASDAQ:FRPH) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Friday.

Top 10 Heal Care Stocks To Buy For 2019: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Intrepid Potash (NYSE:IPI) are falling, down 20.8% as of 12:02 p.m. EDT, after the company announced second-quarter 2018 earnings. The fertilizer producer actually turned in a solid performance compared to the year-ago period for all three of its major business activities — potash, Trio, and water — and more than doubled operating cash flow. Furthermore, management expects the business to continue improving in future periods. 

  • [By Lisa Levin]

    Wednesday morning, the materials shares rose 0.83 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), up 8 percent, and Braskem S.A. (NYSE: BAK) up 6 percent.

  • [By Ethan Ryder]

    Hi-Crush Partners (NYSE: HCLP) and Intrepid Potash (NYSE:IPI) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, institutional ownership, profitability, analyst recommendations and valuation.

  • [By Motley Fool Transcribers]

    Intrepid Potash Inc  (NYSE:IPI)Q4 2018 Earnings Conference CallMarch 12, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Maxx Chatsko]

    While the global fertilizer industry continues to struggle with imbalanced markets, efforts hyper-focused on operational efficiency have begun to pay off for several producers. Investors can count small cap Intrepid Potash (NYSE:IPI) among them.

  • [By Maxx Chatsko]

    Shares of Intrepid Potash (NYSE:IPI) rose as much as 16% today as investors poured back into the stock following a more than 20% drop yesterday, when the fertilizer producer reported second-quarter and first-half 2018 earnings results. While the results were actually pretty good, and demonstrated that the company is executing against its strategy to deliver profitable growth, Wall Street analysts panicked over a miss on the bottom line.

Top 10 Heal Care Stocks To Buy For 2019: Allison Transmission Holdings, Inc.(ALSN)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Allison Transmission Holdings Inc  (NYSE:ALSN)Q4 2018 Earnings Conference CallFeb. 26, 2019, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Allison Transmission (NYSE:ALSN) and ATC Venture Group (OTCMKTS:ATCV) are both auto/tires/trucks companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.

  • [By Stephan Byrd]

    Allison Transmission (NYSE:ALSN) – Investment analysts at Oppenheimer increased their FY2018 earnings per share (EPS) estimates for Allison Transmission in a research note issued on Monday, April 30th. Oppenheimer analyst I. Zaffino now expects that the auto parts company will post earnings of $3.79 per share for the year, up from their previous forecast of $3.32. Oppenheimer also issued estimates for Allison Transmission’s FY2019 earnings at $4.16 EPS.

Top 10 Heal Care Stocks To Buy For 2019: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) jumped 20.9% in August, according to data provided by S&P Global Market Intelligence as investors in the biotech become more comfortable with the potential of Tavalisse, Rigel’s recently approved drug for chronic immune thrombocytopenia, which is characterized by low blood platelet levels.

  • [By Maxx Chatsko]

    Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) climbed over 17% today after the company announced second-quarter and first-half 2018 earnings results. The pharma company reported $1.8 million in net product sales of Tavalisse, the portfolio’s first approved product, during the most recent quarter. That may not seem like much, but not when you consider that the chronic immune thrombocytopenia (ITP) treatment only launched on May 29. 

  • [By Trey Thoelcke]

    Here too, the low price makes this stock an attractive target. Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) is engaged in the discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

  • [By Cory Renauer]

    Here’s why analysts are willing to stick their necks out and predict huge gains ahead for these fledgling drugmakers. Just remember, huge potential rewards usually come with a great deal of risk.

    Company (Symbol) Bank Recent Price Target Implied Upside at Recent Prices
    Tocagen Inc. (NASDAQ:TOCA) Citigroup $27 141%
    Vital Therapies, Inc. (NASDAQ:VTL) Cantor Fitzgerald $18 142%
    Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Citigroup $8.50

    156%

  • [By Logan Wallace]

    Rock Springs Capital Management LP raised its holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) by 4.0% in the first quarter, Holdings Channel reports. The fund owned 2,575,000 shares of the biotechnology company’s stock after buying an additional 100,000 shares during the period. Rock Springs Capital Management LP’s holdings in Rigel Pharmaceuticals were worth $9,116,000 at the end of the most recent reporting period.

Top 10 Heal Care Stocks To Buy For 2019: Liquidity Services Inc.(LQDT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Most people who think about retail focus on the hot products that are always in demand. Yet at the other end of the spectrum are the products that perhaps were once needed but now find themselves either out of fashion or no longer necessary for the typical customer. That’s where Liquidity Services (NASDAQ:LQDT) comes in, offering a way for government and private sector clients to dispose of surplus inventory effectively and efficiently. That niche has challenges of its own, but the company has been making moves to build its business back up and hopefully return to profitability.

  • [By Joseph Griffin]

    Eagle Boston Investment Management Inc. grew its stake in Liquidity Services, Inc. (NASDAQ:LQDT) by 4.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 307,736 shares of the business services provider’s stock after purchasing an additional 12,917 shares during the quarter. Eagle Boston Investment Management Inc. owned approximately 0.96% of Liquidity Services worth $2,015,000 as of its most recent SEC filing.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Heal Care Stocks To Buy For 2019: SunCoke Energy Partners, L.P.(SXCP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) fell 23.3 percent to $9.87 in pre-market trading after declining 13.45 percent on Wednesday.
    SunCoke Energy Partners, L.P. (NYSE: SXCP) fell 12.8 percent to $16.00 in pre-market trading after reporting Q1 results.
    Briggs & Stratton Corporation (NYSE: BGG) fell 11 percent to $17.55 in pre-market trading after the company posted mixed Q3 results and lowered its FY18 guidance.
    New Gold Inc. (NYSE: NGD) fell 8.4 percent to $2.30 in pre-market trading following downbeat Q1 results.
    Quality Care Properties, Inc. (NYSE: QCP) fell 8.2 percent to $20.85 in pre-market trading. Welltower announced plans to acquire QCP for $20.75 per share in cash.
    China Customer Relations Centers Inc. (NASDAQ: CCRC) shares fell 7.5 percent to $17.25 in pre-market trading after climbing 18.73 percent on Wednesday.
    Nokia Corporation (NYSE: NOK) shares fell 5.7 percent to $5.58 in pre-market trading after reporting Q1 results.
    eBay Inc. (NASDAQ: EBAY) fell 5.6 percent to $38.66 in pre-market trading following Q1 results.
    Southw

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on SunCoke Energy Partners (SXCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE: SXCP) and AK Steel (NYSE:AKS) are both small-cap oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top Clean Energy Stocks For 2019

What happened 

Solar stocks took a beating Monday after China cut its national incentives to install solar projects. Shares of solar panel manufacturers Canadian Solar Inc. (NASDAQ:CSIQ) fell as much as 14.5%, JinkoSolar Holding Co. (NYSE:JKS) dropped as much as 17%, and Daqo New Energy Corp (NYSE:DQ) fell as much as 31.3% while inverter manufacturer Enphase Energy Inc (NASDAQ:ENPH) fell up to 13.5%. By early afternoon, most major stocks in the solar industry were down double digits.

So what

There were two pieces of China’s solar ruling, one having to do with distributed generation (DG) and the other with utility-scale solar.

Image source: Getty Images.

On the DG side, China put a cap of 10 gigawatts (GW) for new solar projects in 2018, down from 19 GW installed in 2017. According to Asia Europe Clean Energy Advisory Co (AECEA), there may already be more than 10 GW of DG projects installed in China, so that could make it tough to build any projects in the second half of the year.

Top Clean Energy Stocks For 2019: NextEra Energy, Inc.(NEE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Argent Trust Co lifted its holdings in shares of NextEra Energy Inc (NYSE:NEE) by 67.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,148 shares of the utilities provider’s stock after buying an additional 12,598 shares during the period. Argent Trust Co’s holdings in NextEra Energy were worth $5,414,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NextEra Energy (NEE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Shane Hupp]

    Shares of NextEra Energy Inc (NYSE:NEE) have been given an average recommendation of “Buy” by the fourteen analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $178.75.

  • [By Joseph Griffin]

    Wendell David Associates Inc. raised its stake in NextEra Energy Inc (NYSE:NEE) by 1.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 54,474 shares of the utilities provider’s stock after acquiring an additional 760 shares during the period. NextEra Energy accounts for about 1.4% of Wendell David Associates Inc.’s investment portfolio, making the stock its 20th biggest holding. Wendell David Associates Inc.’s holdings in NextEra Energy were worth $9,130,000 as of its most recent filing with the Securities & Exchange Commission.

Top Clean Energy Stocks For 2019: TriMas Corporation(TRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    TriMas (NASDAQ: TRS) and Shiloh Industries (NASDAQ:SHLO) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings.

  • [By Max Byerly]

    Liberum Capital reissued their buy rating on shares of Tarsus Group (LON:TRS) in a research report released on Friday.

    A number of other analysts have also commented on the company. Peel Hunt reaffirmed a buy rating on shares of Tarsus Group in a research report on Friday, June 29th. Deutsche Bank initiated coverage on Tarsus Group in a report on Tuesday, June 26th. They set a buy rating and a GBX 360 ($4.69) price objective for the company. Finally, Numis Securities reissued a buy rating on shares of Tarsus Group in a report on Thursday, July 26th.

  • [By Ethan Ryder]

    Shares of TriMas Co. (NASDAQ:TRS) hit a new 52-week high and low during trading on Monday . The company traded as low as $28.95 and last traded at $28.20, with a volume of 1202 shares trading hands. The stock had previously closed at $28.60.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on TriMas (TRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    TriMas (NASDAQ:TRS) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

Top Clean Energy Stocks For 2019: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    Here too, the low price makes this stock an attractive target. Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) is engaged in the discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Rigel Pharmaceuticals (RIGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

  • [By Cory Renauer]

    Here’s why analysts are willing to stick their necks out and predict huge gains ahead for these fledgling drugmakers. Just remember, huge potential rewards usually come with a great deal of risk.

    Company (Symbol) Bank Recent Price Target Implied Upside at Recent Prices
    Tocagen Inc. (NASDAQ:TOCA) Citigroup $27 141%
    Vital Therapies, Inc. (NASDAQ:VTL) Cantor Fitzgerald $18 142%
    Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Citigroup $8.50

    156%

Top Clean Energy Stocks For 2019: Woori Bank(WF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Woori Bank (NYSE:WF) and ANZ (OTCMKTS:ANZBY) are both large-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Wells Fargo (WF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    News headlines about Woori Bank (NYSE:WF) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Woori Bank earned a news sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the bank an impact score of 46.2147954877183 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top Clean Energy Stocks For 2019: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Max Byerly]

    Vermillion, Inc. (NASDAQ:VRML) CFO Robert Harry Beechey acquired 75,000 shares of the company’s stock in a transaction that occurred on Thursday, August 23rd. The shares were acquired at an average cost of $0.61 per share, for a total transaction of $45,750.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Stephan Byrd]

    Media headlines about Vermillion (NASDAQ:VRML) have been trending somewhat positive this week, Accern reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Vermillion earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.6924212135165 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Vermillion (NASDAQ: VRML) and Myriad Genetics (NASDAQ:MYGN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

  • [By Benzinga News Desk]

    Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

    ECONOMIC DATA
    US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M
    Existing home sales report for April will be released at 10:00 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.
    Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET.
    The Treasury is set to auction 7-year notes at 1:00 p.m. ET.
    The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET.
    Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET.
    Data on money supply for the latest week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    UBS upgrades Deere (NYSE: DE) from Neutral to Buy
    Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform
    Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold
    Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Top Clean Energy Stocks For 2019: Basilea Pharmaceutica Ltd. (BPMUF)

Advisors’ Opinion:

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 High Tech Stocks To Buy For 2019

U.S. stock were trading tepidly lower Thursday, in choppy early moves, as investors remained tentative ahead of a key meeting between President Donald Trump and his Chinese counterpart Xi Jinping.

Thursdays action follows the biggest one-day reversal for equities in more than a year in the previous session which was triggered in part by the Federal Reserves admission that it will start unwinding its balance sheet sooner than expected.

Top 5 High Tech Stocks To Buy For 2019: National Health Investors, Inc.(NHI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Virginia Retirement Systems ET AL lifted its position in shares of National Health Investors, Inc. (NYSE:NHI) by 10.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,300 shares of the real estate investment trust’s stock after acquiring an additional 10,700 shares during the period. Virginia Retirement Systems ET AL owned approximately 0.28% of National Health Investors worth $7,826,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    Shares of National Health Investors, Inc. (NYSE:NHI) have received a consensus rating of “Hold” from the thirteen analysts that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $71.43.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on National Health Investors (NHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 High Tech Stocks To Buy For 2019: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
    Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
    Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
    Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
    CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
    NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
    Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
    Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
    Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
    Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

    Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.

Top 5 High Tech Stocks To Buy For 2019: Virtusa Corporation(VRTU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Virtusa (VRTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Great Lakes Advisors LLC grew its holdings in shares of Virtusa (NASDAQ:VRTU) by 38.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,531 shares of the information technology services provider’s stock after buying an additional 45,860 shares during the quarter. Great Lakes Advisors LLC owned 0.57% of Virtusa worth $8,070,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Virtusa (NASDAQ:VRTU) – Equities research analysts at SunTrust Banks issued their Q1 2020 earnings per share (EPS) estimates for shares of Virtusa in a report released on Wednesday, May 16th. SunTrust Banks analyst F. Atkins expects that the information technology services provider will post earnings of $0.33 per share for the quarter. SunTrust Banks currently has a “Hold” rating on the stock. SunTrust Banks also issued estimates for Virtusa’s Q2 2020 earnings at $0.46 EPS, Q3 2020 earnings at $0.56 EPS and Q4 2020 earnings at $0.60 EPS.

Top 5 High Tech Stocks To Buy For 2019: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Rock Springs Capital Management LP raised its holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) by 4.0% in the first quarter, Holdings Channel reports. The fund owned 2,575,000 shares of the biotechnology company’s stock after buying an additional 100,000 shares during the period. Rock Springs Capital Management LP’s holdings in Rigel Pharmaceuticals were worth $9,116,000 at the end of the most recent reporting period.

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Rigel Pharmaceuticals (RIGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 High Tech Stocks To Buy For 2019: Mimecast Limited(MIME)

Advisors’ Opinion:

  • [By Todd Campbell and Timothy Green]

    Buying and holding shares in great companies like eBayfor the long haul has proven to be very profit-friendly, but identifying growth stocks early on isn’t easy. To help find tomorrow’s winners, we asked two Motley Fool investors which burgeoning growth stocks are on their radar right now. They responded with Skechers (NYSE:SKX)and Mimecast (NASDAQ:MIME). Read on to find out if these stocks deserve a spot in your portfolio.

  • [By Garrett Baldwin]

    Eight Seconds… $1,260 Richer: Words can’t describe what you’ll see in this shocking footage – because you’ll witness, live on camera, one man become $4,238 richer with just three clicks of a mouse. And if you follow the simple instructions in this video, you’ll learn how to set yourself up for an instant $2,918 payday opportunity. You need to see this to believe it…

    Three Stocks to Watch Today: COP, HD, HSBC
    ConocoPhillips (NYSE: COP) has seized assets from the Venezuelan-owned firm PDVSA in the Caribbean. The company won a court case that will allow it to take over assets owned by the Venezuelan government. The court enabled the seizures as part of a broader plan to allow the firm to recoup roughly $2 billion following the 2007 nationalization of its assets in Venezuela by the huge Castro-led government.
    Monday will be a quiet day on the earnings front. Investors are looking to Tuesday’s calendar, when The Home Depot Inc. (NYSE: HD) reports earnings. Tomorrow, Wall Street analysts expect that Home Depot will report earnings per share of $2.07 on top of $25.2 billion in revenue. Investors will be hoping that the company reports strong profits thanks to an improving U.S. economy and the recent tax reform law.
    Expect a lot of chatter today about blockchain technology. That’s because ING Bank and HSBC Holdings Plc.(NYSE: HSBC) announced over the weekend that they engaged in their first trade ever using blockchain technology. The two engaged in a trade on behalf of Cargill to finance a shipment of soybeans from Argentina to Malaysia.
    Today, look for earnings reports from Agilent Technologies (NYSE: A), Itron Inc.(Nasdaq: ITRI), Vipshop Holdings Ltd.(Nasdaq: VIPS), Amyris Biotechnologies Inc. (Nasdaq: AMRS), Sky Solar Holdings Ltd.(Nasdaq: SKYS), Mazor Robotics Ltd.(Nasdaq: MZOR), China Lodging Group Ltd. (Nasdaq: HTHT), and Mimecast Ltd.(Nasdaq: MIME).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

  • [By Todd Campbell]

    Investing in emerging growth stocks for the long haul can be a great way to produce market-beating returns, but with thousands of stocks to choose from, it can be tough figuring out which are worth owning. To help, I went searching for growth stocks that can be added to portfolios and pickedAtlassian Corp. (NASDAQ:TEAM), Mimecast (NASDAQ:MIME), and 2U Inc. (NASDAQ:TWOU) as my favorite stocks to buy in May. Read on to learn if these stocks are right for your portfolio, too.

Best Stocks To Own Right Now

&l;p&g;Some 44% of professionals often lose sleep over work, according to &l;a href=&q;http://rh-us.mediaroom.com/2018-03-07-Sleepless-In-Miami-Nashville-And-New-York-Survey-Finds-44-Percent-Of-Professionals-Often-Lose-Sleep-Over-Work&q; target=&q;_blank&q;&g;new research from global staffing firm Accountemps&l;/a&g;. Many are overwhelmed by work volume (50%), have trouble getting a business problem out of their head (48%) or are bugged by a strained coworker relationship (20%).

&q;Work stressors can often follow you home, but try to check them at the door,&q; said Michael Steinitz, executive director of Accountemps, in a press release. &q;If you have too much on your plate, schedule time with your manager to discuss possible solutions to alleviate the pressure, such as delegating work to others, adjusting deadlines or bringing in temporary help.&q;

If work angst is keeping you up at night, here are some strategies for dialing down your stress levels.

&l;strong&g;Find something creative to do when you get overloaded.&l;/strong&g; &a;ldquo;What I do is I play piano,&a;rdquo; says Gene Caballero, co-founder of lawn care company GreenPal. &a;ldquo;It&a;rsquo;s fun, it&a;rsquo;s something I look forward to doing, and playing an instrument has been scientifically proven to engage practically every area of the brain at once, so it gets my mental capacity going. It&a;rsquo;s like a mental full body workout.&a;rdquo;

Best Stocks To Own Right Now: Lakeland Industries, Inc.(LAKE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Alpine Woods Capital Investors LLC reduced its position in Lakeland Industries (NASDAQ:LAKE) by 40.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,010 shares of the medical instruments supplier’s stock after selling 10,000 shares during the quarter. Alpine Woods Capital Investors LLC owned about 0.18% of Lakeland Industries worth $194,000 at the end of the most recent quarter.

Best Stocks To Own Right Now: United Insurance Holdings Corp.(UIHC)

Advisors’ Opinion:

  • [By Shane Hupp]

    United Insurance (NASDAQ:UIHC) announced its quarterly earnings results on Tuesday. The insurance provider reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.02, Bloomberg Earnings reports. United Insurance had a return on equity of 9.16% and a net margin of 2.05%. The company had revenue of $182.36 million during the quarter, compared to analyst estimates of $178.33 million.

Best Stocks To Own Right Now: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

Top 10 Warren Buffett Stocks To Own Right Now

Move over Warren Buffett! Amazon CEO Jeff Bezos is now the second richest person on Earth.

The latest tally by Bloomberg’s Billionaires Index shows Bezos is now worth about $75.6 billion. Another ranking compiled by Forbes has Bezos’ value at “just” $75.2 billion.

He added $1.5 billion to his net worth after Amazon (AMZN, Tech30) gained $9 billion in market value during trading hours Wednesday.

The company received a generous stock bump after a Barclay’s (AGRPY) analyst declared Amazon will “likely to be one of the first trillion-dollar market cap companies.” Its shares hit a record high shortly after.

Amazon’s stock has been on fire lately — it’s grown more than 16% over the last year. Investors were pleased with the company’s decision, announced yesterday, to buy Souq, an e-commerce giant in the Middle East.

Amazon isn’t Bezos’s only venture. He also owns space exploration company Blue Origin. Its goal is to eventually take people on “space tourism” trips and to deliver satellites into orbit for corporate climates. So far, the company has only conducted test flights.

Top 10 Warren Buffett Stocks To Own Right Now: NeoGenomics, Inc.(NEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    NeoGenomics (NASDAQ:NEO) has been given a consensus recommendation of “Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $17.29.

  • [By Shane Hupp]

    NEO (CURRENCY:NEO) traded up 6.9% against the US dollar during the 24 hour period ending at 7:00 AM Eastern on April 15th. NEO has a total market cap of $4.40 billion and $88.39 million worth of NEO was traded on exchanges in the last day. One NEO coin can now be purchased for about $67.68 or 0.00809123 BTC on popular cryptocurrency exchanges including HitBTC, OKEx, Exrates and Upbit. During the last seven days, NEO has traded up 42.9% against the US dollar.

Top 10 Warren Buffett Stocks To Own Right Now: NIC Inc.(EGOV)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of NIC (NASDAQ:EGOV) from a buy rating to a strong-buy rating in a research note published on Friday morning.

    Several other research firms also recently commented on EGOV. Zacks Investment Research downgraded NIC from a hold rating to a sell rating in a report on Monday, January 8th. ValuEngine downgraded NIC from a sell rating to a strong sell rating in a report on Wednesday, May 2nd. Barrington Research restated a hold rating on shares of NIC in a report on Monday, April 30th. TheStreet downgraded NIC from a b- rating to a c rating in a report on Thursday, March 8th. Finally, Loop Capital decreased their price objective on NIC to $14.00 and set a hold rating for the company in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $18.33.

Top 10 Warren Buffett Stocks To Own Right Now: VSE Corporation(VSEC)

Advisors’ Opinion:

  • [By Max Byerly]

    VSE (NASDAQ:VSEC) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Monday.

Top 10 Warren Buffett Stocks To Own Right Now: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

Top 10 Warren Buffett Stocks To Own Right Now: Premier, Inc.(PINC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Premier (PINC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

Top 10 Warren Buffett Stocks To Own Right Now: Liberty Global plc(LILA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Dish Network (NASDAQ: DISH) and Liberty Latin America (NASDAQ:LILA) are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

  • [By Ethan Ryder]

    Liberty Latin America (NASDAQ:LILA) has been assigned a consensus rating of “Hold” from the ten ratings firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $24.75.

Top 10 Warren Buffett Stocks To Own Right Now: Yuma Energy, Inc.(YUMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) disclosed that it received the FDA approval for Calcium Chloride injection.
    Rapid7, Inc. (NASDAQ: RPD) reported a proposed offering of 3 million shares.
    Yuma Energy Inc (NYSE: YUMA) reported a Q1 loss of $0.16 per share on sales of $5.646 million. The company also disclosed that it is actively seeking strategic alternatives.
    NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders.

  • [By Lisa Levin]

    Shares of Yuma Energy, Inc. (NYSE: YUMA) were down 60 percent to $0.4520 after the company late Friday reported it was not in compliance with its debt to EBITDAX covenant and announced limited liquidity levels. The company also reported Q1 earnings down year-over-year and disclosed that it is exploring strategic alternatives.

Top 10 Warren Buffett Stocks To Own Right Now: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By George Budwell]

    When it comes to biotech stocks, Celgene(NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD) are easily two of the brightest stars. After all, these two top dogs have generated enormous returns for investors since the start of the biotech bull market back in 2010:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Gilead Sciences, Inc. (NASDAQ: GILD) which rose about 4% to $88.78. The stocks 52-week range is $63.76 to $89.54. Volume was roughly 18 million compared to the daily average volume of about 8 million.

  • [By George Budwell]

    After releasing downright worrisome first-quarter results, Gilead Sciences (NASDAQ:GILD) has seen its shares drop by a noteworthy 11.7% in the past few days. The big concern is that Gilead’s ailing hepatitis C franchise has yet to stabilize in the wake of newfound competition from AbbVie’s (NYSE:ABBV)Mavyret.

  • [By Keith Speights]

    AbbVie’s new hepatitis C virus (HCV) drug Mavyretappears to be giving Gilead Sciences (NASDAQ:GILD) a run for its money. In the first quarter, AbbVie’s net HCV revenue came in at $919 million. That total includes both of the company’s HCV drugs, Viekira and Mavyret. But there’s virtually no question that Mavyret is contributing most of AbbVie’s HCV revenue.

  • [By ]

    Booker’s report took on other companies as well. Pfizer (PFE) , Gilead Sciences (GILD) , AbbVie  (ABBV) , Amgen (AMGN) , Bristol-Myers Squibb (BMY) Eli Lilly & Co. (LLY) , and Mylan NV (MYL) are cited for everything from raising drug prices, to stock buybacks and putting shareholder interest before that of the public.

Top 10 Warren Buffett Stocks To Own Right Now: QuinStreet, Inc.(QNST)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The mood was negative on Wall Street on Wednesday, and most major benchmarks finished in the red. Strength in the technology sector wasn’t enough to lift more cyclically focused benchmarks like the Dow Jones Industrial Average, and the combination of an attack on Saudi Arabia that sent oil prices higher and some disquieting readings on the inflation front kept investors from feeling more confident about stocks going into earnings season. In addition, some individual companies had bad news that sent their shares lower. Analogic (NASDAQ:ALOG), QuinStreet (NASDAQ:QNST), and MSC Industrial Direct (NYSE:MSM) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Warren Buffett Stocks To Own Right Now: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded down 9.1% against the U.S. dollar during the 24-hour period ending at 11:00 AM Eastern on May 12th. One Blue Protocol token can now be purchased for about $0.18 or 0.00002166 BTC on cryptocurrency exchanges including CoinExchange, EtherDelta (ForkDelta), IDEX and YoBit. In the last seven days, Blue Protocol has traded down 16.3% against the U.S. dollar. Blue Protocol has a market capitalization of $6.65 million and $31,443.00 worth of Blue Protocol was traded on exchanges in the last 24 hours.

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Todd Campbell, Leo Sun, and Daniel Miller]

    For instance, the company recently acquired Juno Therapeutics to get its hands on a pipeline of chimeric antigen receptor T-cell gene therapies (CAR-Ts). CAR-Ts represent one of the biggest recent advances in treating blood cancer, and depending on trial results, the first CAR-T from this collaboration could be filed for approval next year. Similarly, Celgene is partnering with bluebird bio (NASDAQ:BLUE) on bb2121, a CAR-T for multiple myeloma. So far, bb2121 is delivering 90%-plus response rates in heavily pre-treated patients, and if that success continues, it could end up on regulators’ desk for approval next year, too.

  • [By Rafi Farber]

    Heres some perspective. Within the past decade, University of Pennsylvania has allied with Novartis A.G. (NYSE: NVS), Baylor College of Medicine with Bluebird Bio Inc. (NASDAQ: BLUE) and Celgene Corp. (NASDAQ:CELG), Memorial Sloan Kettering Cancer Center and the Fred Hutchinson Cancer Research Center with Juno Therapeutics Inc. (NASDAQ: JUNO) (which Celgene just got clearance to acquire), and the National Cancer Institute with Kite Pharma, which was acquired last year byGilead Sciences Inc. (NASDAQ: GILD).